lOMoARcPSD| 117 ‗ ‗
005 91
,Table ‘of ‘Contents
Chapter ‗01: ‗Introduction ‗to ‗Pathophysiology ‗Test ‗Bank....................................................................................... 1
Chapter ‗02: ‗Fluid, ‗Electrolyte, ‗and ‗Acid-Base ‗Imbalances ‗Test ‗Bank................................................................. 9
Chapter ‗03: ‗Introduction ‗to ‗Basic ‗Pharmacology ‗and ‗Other ‗Common ‗Therapies ‗Test ‗Bank........................... 18
Chapter ‗04: ‗Pain ‗Test ‗Bank .................................................................................................................................. 21
Chapter ‗05: ‗Inflammation ‗and ‗Healing ‗Test ‗Bank .............................................................................................. 25
Chapter ‗06: ‗Infection ‗Test ‗Bank........................................................................................................................... 36
Chapter ‗07: ‗Immunity ‗Test ‗Bank.......................................................................................................................... 44
Chapter ‗08: ‗Skin ‗Disorders ‗Test ‗Bank................................................................................................................. 50
Chapter ‗09: ‗Musculoskeletal ‗Disorders ‗Test ‗Bank .............................................................................................. 55
Chapter ‗10: ‗Blood ‗and ‗Circulatory ‗System ‗Disorders ‗Test ‗Bank ...................................................................... 63
Chapter ‗11: ‗Lymphatic ‗System ‗Disorders ‗Test ‗Bank ......................................................................................... 71
Chapter ‗12: ‗Cardiovascular ‗System ‗Disorders ‗Test ‗Bank ................................................................................... 73
Chapter ‗13: ‗Respiratory ‗System ‗Disorders ‗Test ‗Bank ........................................................................................ 90
Chapter ‗14: ‗Neurological ‗Disorders ‗Test ‗Bank ................................................................................................. 107
Chapter ‗15: ‗Disorders ‗of ‗the ‗Eye, ‗Ear, ‗and ‗Other ‗Sensory ‗Organs ‗Test ‗Bank .............................................. 124
Chapter ‗16: ‗Endocrine ‗System ‗Disorders ‗Test ‗Bank ........................................................................................ 130
Chapter ‗17: ‗Digestive ‗System ‗Disorders ‗Test ‗Bank ......................................................................................... 141
Chapter ‗18: ‗Urinary ‗System ‗Disorders ‗Test ‗Bank ............................................................................................ 159
Chapter ‗19: ‗Reproductive ‗System ‗Disorders ‗Test ‗Bank ................................................................................... 170
Chapter ‗20: ‗Neoplasms ‗and ‗Cancer ‗Test ‗Bank ................................................................................................. 178
Chapter ‗21: ‗Congenital ‗and ‗Genetic ‗Disorders ‗Test ‗Bank ............................................................................... 184
Chapter ‗22: ‗Complications ‗due ‗to ‗Pregnancy ‗Test ‗Bank .................................................................................. 190
Chapter ‗23: ‗Complications ‗due ‗to ‗Adolescence ‗Test ‗Bank .............................................................................. 193
Chapter ‗24: ‗Complications ‗due ‗to ‗Aging ‗Test ‗Bank ........................................................................................ 196
Chapter ‗25: ‗Immobility ‗and ‗Associated ‗Problems ‗Test ‗Bank........................................................................... 199
Chapter ‗26: ‗Stress ‗and ‗Associated ‗Problems ‗Test ‗Bank................................................................................... 202
Chapter ‗27: ‗Substance ‗Abuse ‗and ‗Associated ‗Problems ‗Test ‗Bank ................................................................ 204
Chapter ‗28: ‗Environmental ‗Hazards ‗and ‗Associated ‗Problems ‗Test ‗Bank ...................................................... 207
,Chapter ‘01: ‘Introduction ‘to ‘Pathophysiology
‘Test ‘Bank
MULTIPLE ‘CHOICE
1. Which ‗of ‗the ‗following ‗would ‗be ‗the ‗most ‗likely ‗cause ‗of ‗an ‗iatrogenic ‗disease?
a. An ‗inherited ‗disorder
b. A ‗combination ‗of ‗specific ‗etiological ‗factors
c. An ‗unwanted ‗effect ‗of ‗a ‗prescribed ‗drug
d. Prolonged ‗exposure ‗to ‗toxic ‗chemicals ‗in ‗the ‗environment
ANS: ‘ C REF: ‗6
2. The ‗manifestations ‗of ‗a ‗disease ‗are ‗best ‗defined ‗as ‗the:
a. subjective ‗feelings ‗of ‗discomfort ‗during ‗a ‗chronic ‗illness.
b. signs ‗and ‗symptoms ‗of ‗a ‗disease.
c. factors ‗that ‗precipitate ‗an ‗acute ‗episode ‗of ‗a ‗chronic ‗illness.
d. early ‗indicators ‗of ‗the ‗prodromal ‗stage ‗of ‗infection.
ANS: ‘ B REF: ‗6
3. The ‗best ‗definition ‗of ‗the ‗term ‗prognosis ‘is ‗the:
a. precipitating ‗factors ‗causing ‗an ‗acute ‗episode.
b. number ‗of ‗remissions ‗to ‗be ‗expected ‗during ‗the ‗course ‗of ‗a ‗chronic ‗illness.
c. predicted ‗outcome ‗or ‗likelihood ‗of ‗recovery ‗from ‗a ‗specific ‗disease.
d. exacerbations ‗occurring ‗during ‗chronic ‗illness.
ANS: ‘ C REF: ‗7
4. Which ‗of ‗the ‗following ‗is ‗considered ‗a ‗systemic ‗sign ‗of ‗disease?
a. Swelling ‗of ‗the ‗knee
b. Fever
c. Pain ‗in ‗the ‗neck
d. Red ‗rash ‗on ‗the ‗face
ANS: ‘ B REF: ‗6
5. Etiology ‗is ‗defined ‗as ‗the ‗study ‗of ‗the:
a. causes ‗of ‗a ‗disease.
b. course ‗of ‗a ‗disease.
c. expected ‗complications ‗of ‗a ‗disease.
d. manifestations ‗of ‗a ‗disease.
ANS: ‘ A REF: ‗5
6. A ‗type ‗of ‗cellular ‗adaptation ‗in ‗which ‗there ‗is ‗a ‗decrease ‗in ‗cell ‗size ‗is ‗referred ‗to ‗as:
a. hypertrophy.
b. metaplasia.
c. anaplasia.
d. atrophy.
ANS: ‘ D REF: ‗8
1
, lOMoARcPSD| 117 005 91
GOULDS PATHOPHYSIOLOGY FOR THE HEALTH PROFESSIONS 6TH EDITION HUBERT TEST BANK
7. A ‗change ‗in ‗a ‗tissue ‗marked ‗by ‗cells ‗that ‗vary ‗in ‗size ‗and ‗shape ‗and ‗show ‗increased
‗mitotic ‗figures ‗would ‗be ‗called:
a. metaplasia.
b. atrophy.
c. dysplasia.
d. hypertrophy.
ANS: ‘ C REF: ‗8
8. A ‗deficit ‗of ‗oxygen ‗in ‗the ‗cells ‗usually ‗due ‗to ‗respiratory ‗or ‗circulatory ‗problems ‗is ‗called:
a. apoptosis.
b. ischemia.
c. hypertrophy.
d. necrosis.
ANS: ‘ B REF: ‗9
9. When ‗a ‗group ‗of ‗cells ‗in ‗the ‗body ‗dies, ‗the ‗change ‗is ‗called:
a. ischemia.
b. gangrene.
c. hypoxia.
d. necrosis.
ANS: ‘ D REF: ‗10
10. Rigorous ‗weight ‗lifting/body ‗building ‗regimens ‗may ‗result ‗in ‗the ‗skeletal ‗muscle
‗cells ‗undergoing:
a. hypertrophy.
b. dysplasia.
c. atrophy.
d. regeneration.
ANS: ‘ A REF: ‗8
11. The ‗term ‗cancer ‘refers ‗to:
a. dysplasia.
b. hyperplasia.
c. metaplasia.
d. malignant ‗neoplasm.
ANS: ‘ D REF: ‗9
12. To ‗which ‗of ‗the ‗following ‗does ‗the ‗term ‗apoptosis ‘refer?
a. Increased ‗rate ‗of ‗mitosis ‗by ‗certain ‗cells
b. Ischemic ‗damage ‗to ‗cells
c. Liquefaction ‗of ‗necrotic ‗tissue
d. Preprogrammed ‗cell ‗self-destruction
ANS: ‘ D REF: ‗9
13. Which ‗of ‗the ‗following ‗statements ‗is ‗TRUE?
a. Alteration ‗of ‗DNA ‗does ‗not ‗change ‗cell ‗function.
005 91
,Table ‘of ‘Contents
Chapter ‗01: ‗Introduction ‗to ‗Pathophysiology ‗Test ‗Bank....................................................................................... 1
Chapter ‗02: ‗Fluid, ‗Electrolyte, ‗and ‗Acid-Base ‗Imbalances ‗Test ‗Bank................................................................. 9
Chapter ‗03: ‗Introduction ‗to ‗Basic ‗Pharmacology ‗and ‗Other ‗Common ‗Therapies ‗Test ‗Bank........................... 18
Chapter ‗04: ‗Pain ‗Test ‗Bank .................................................................................................................................. 21
Chapter ‗05: ‗Inflammation ‗and ‗Healing ‗Test ‗Bank .............................................................................................. 25
Chapter ‗06: ‗Infection ‗Test ‗Bank........................................................................................................................... 36
Chapter ‗07: ‗Immunity ‗Test ‗Bank.......................................................................................................................... 44
Chapter ‗08: ‗Skin ‗Disorders ‗Test ‗Bank................................................................................................................. 50
Chapter ‗09: ‗Musculoskeletal ‗Disorders ‗Test ‗Bank .............................................................................................. 55
Chapter ‗10: ‗Blood ‗and ‗Circulatory ‗System ‗Disorders ‗Test ‗Bank ...................................................................... 63
Chapter ‗11: ‗Lymphatic ‗System ‗Disorders ‗Test ‗Bank ......................................................................................... 71
Chapter ‗12: ‗Cardiovascular ‗System ‗Disorders ‗Test ‗Bank ................................................................................... 73
Chapter ‗13: ‗Respiratory ‗System ‗Disorders ‗Test ‗Bank ........................................................................................ 90
Chapter ‗14: ‗Neurological ‗Disorders ‗Test ‗Bank ................................................................................................. 107
Chapter ‗15: ‗Disorders ‗of ‗the ‗Eye, ‗Ear, ‗and ‗Other ‗Sensory ‗Organs ‗Test ‗Bank .............................................. 124
Chapter ‗16: ‗Endocrine ‗System ‗Disorders ‗Test ‗Bank ........................................................................................ 130
Chapter ‗17: ‗Digestive ‗System ‗Disorders ‗Test ‗Bank ......................................................................................... 141
Chapter ‗18: ‗Urinary ‗System ‗Disorders ‗Test ‗Bank ............................................................................................ 159
Chapter ‗19: ‗Reproductive ‗System ‗Disorders ‗Test ‗Bank ................................................................................... 170
Chapter ‗20: ‗Neoplasms ‗and ‗Cancer ‗Test ‗Bank ................................................................................................. 178
Chapter ‗21: ‗Congenital ‗and ‗Genetic ‗Disorders ‗Test ‗Bank ............................................................................... 184
Chapter ‗22: ‗Complications ‗due ‗to ‗Pregnancy ‗Test ‗Bank .................................................................................. 190
Chapter ‗23: ‗Complications ‗due ‗to ‗Adolescence ‗Test ‗Bank .............................................................................. 193
Chapter ‗24: ‗Complications ‗due ‗to ‗Aging ‗Test ‗Bank ........................................................................................ 196
Chapter ‗25: ‗Immobility ‗and ‗Associated ‗Problems ‗Test ‗Bank........................................................................... 199
Chapter ‗26: ‗Stress ‗and ‗Associated ‗Problems ‗Test ‗Bank................................................................................... 202
Chapter ‗27: ‗Substance ‗Abuse ‗and ‗Associated ‗Problems ‗Test ‗Bank ................................................................ 204
Chapter ‗28: ‗Environmental ‗Hazards ‗and ‗Associated ‗Problems ‗Test ‗Bank ...................................................... 207
,Chapter ‘01: ‘Introduction ‘to ‘Pathophysiology
‘Test ‘Bank
MULTIPLE ‘CHOICE
1. Which ‗of ‗the ‗following ‗would ‗be ‗the ‗most ‗likely ‗cause ‗of ‗an ‗iatrogenic ‗disease?
a. An ‗inherited ‗disorder
b. A ‗combination ‗of ‗specific ‗etiological ‗factors
c. An ‗unwanted ‗effect ‗of ‗a ‗prescribed ‗drug
d. Prolonged ‗exposure ‗to ‗toxic ‗chemicals ‗in ‗the ‗environment
ANS: ‘ C REF: ‗6
2. The ‗manifestations ‗of ‗a ‗disease ‗are ‗best ‗defined ‗as ‗the:
a. subjective ‗feelings ‗of ‗discomfort ‗during ‗a ‗chronic ‗illness.
b. signs ‗and ‗symptoms ‗of ‗a ‗disease.
c. factors ‗that ‗precipitate ‗an ‗acute ‗episode ‗of ‗a ‗chronic ‗illness.
d. early ‗indicators ‗of ‗the ‗prodromal ‗stage ‗of ‗infection.
ANS: ‘ B REF: ‗6
3. The ‗best ‗definition ‗of ‗the ‗term ‗prognosis ‘is ‗the:
a. precipitating ‗factors ‗causing ‗an ‗acute ‗episode.
b. number ‗of ‗remissions ‗to ‗be ‗expected ‗during ‗the ‗course ‗of ‗a ‗chronic ‗illness.
c. predicted ‗outcome ‗or ‗likelihood ‗of ‗recovery ‗from ‗a ‗specific ‗disease.
d. exacerbations ‗occurring ‗during ‗chronic ‗illness.
ANS: ‘ C REF: ‗7
4. Which ‗of ‗the ‗following ‗is ‗considered ‗a ‗systemic ‗sign ‗of ‗disease?
a. Swelling ‗of ‗the ‗knee
b. Fever
c. Pain ‗in ‗the ‗neck
d. Red ‗rash ‗on ‗the ‗face
ANS: ‘ B REF: ‗6
5. Etiology ‗is ‗defined ‗as ‗the ‗study ‗of ‗the:
a. causes ‗of ‗a ‗disease.
b. course ‗of ‗a ‗disease.
c. expected ‗complications ‗of ‗a ‗disease.
d. manifestations ‗of ‗a ‗disease.
ANS: ‘ A REF: ‗5
6. A ‗type ‗of ‗cellular ‗adaptation ‗in ‗which ‗there ‗is ‗a ‗decrease ‗in ‗cell ‗size ‗is ‗referred ‗to ‗as:
a. hypertrophy.
b. metaplasia.
c. anaplasia.
d. atrophy.
ANS: ‘ D REF: ‗8
1
, lOMoARcPSD| 117 005 91
GOULDS PATHOPHYSIOLOGY FOR THE HEALTH PROFESSIONS 6TH EDITION HUBERT TEST BANK
7. A ‗change ‗in ‗a ‗tissue ‗marked ‗by ‗cells ‗that ‗vary ‗in ‗size ‗and ‗shape ‗and ‗show ‗increased
‗mitotic ‗figures ‗would ‗be ‗called:
a. metaplasia.
b. atrophy.
c. dysplasia.
d. hypertrophy.
ANS: ‘ C REF: ‗8
8. A ‗deficit ‗of ‗oxygen ‗in ‗the ‗cells ‗usually ‗due ‗to ‗respiratory ‗or ‗circulatory ‗problems ‗is ‗called:
a. apoptosis.
b. ischemia.
c. hypertrophy.
d. necrosis.
ANS: ‘ B REF: ‗9
9. When ‗a ‗group ‗of ‗cells ‗in ‗the ‗body ‗dies, ‗the ‗change ‗is ‗called:
a. ischemia.
b. gangrene.
c. hypoxia.
d. necrosis.
ANS: ‘ D REF: ‗10
10. Rigorous ‗weight ‗lifting/body ‗building ‗regimens ‗may ‗result ‗in ‗the ‗skeletal ‗muscle
‗cells ‗undergoing:
a. hypertrophy.
b. dysplasia.
c. atrophy.
d. regeneration.
ANS: ‘ A REF: ‗8
11. The ‗term ‗cancer ‘refers ‗to:
a. dysplasia.
b. hyperplasia.
c. metaplasia.
d. malignant ‗neoplasm.
ANS: ‘ D REF: ‗9
12. To ‗which ‗of ‗the ‗following ‗does ‗the ‗term ‗apoptosis ‘refer?
a. Increased ‗rate ‗of ‗mitosis ‗by ‗certain ‗cells
b. Ischemic ‗damage ‗to ‗cells
c. Liquefaction ‗of ‗necrotic ‗tissue
d. Preprogrammed ‗cell ‗self-destruction
ANS: ‘ D REF: ‗9
13. Which ‗of ‗the ‗following ‗statements ‗is ‗TRUE?
a. Alteration ‗of ‗DNA ‗does ‗not ‗change ‗cell ‗function.
